Wettstein M, Häussinger D
Klinik für Gastroenterologie, Hepatologie und Infektiologie, Heinrich Heine-Universität Düsseldorf.
Praxis (Bern 1994). 2001 Jan 11;90(1-2):15-20.
The incidence of the hepatocellular carcinoma (HCC) is increasing in western countries mainly due to chronic hepatitis C. Therapy is dependent on the size and localization of the tumors as well as age and condition of the patient. If resection or transplantation are not possible, smaller tumors can be treated with local therapy either by percutaneous ethanol instillation, radiofrequency ablation or laser thermocoagulation. Larger tumors can be treated by transarterial chemoembolization which can also be combined with the methods named above. The results of systemic chemotherapy and medical treatment are disappointing. With early diagnosis and individualized therapeutic strategies prolongation of life or healing may be reached in many patients.
在西方国家,肝细胞癌(HCC)的发病率正在上升,主要原因是丙型肝炎慢性感染。治疗方法取决于肿瘤的大小、位置以及患者的年龄和身体状况。如果无法进行手术切除或移植,较小的肿瘤可以通过经皮乙醇注射、射频消融或激光热凝等局部治疗方法进行治疗。较大的肿瘤可以通过经动脉化疗栓塞治疗,也可以与上述方法联合使用。全身化疗和药物治疗的效果并不理想。通过早期诊断和个体化治疗策略,许多患者可能实现延长生命或治愈。